Solid Tumors | Norton Children's

By: Norton Healthcare

April 17, 2026

Share:

Phase I/II Study of Silmitasertib (CX-4945) in Combination With Chemotherapy in Children and Young Adults with Relapsed Refractory Solid Tumors

Subscribe Now Share Your Story

Categories

Uncategorized

Related Stories